TARO — Taro Pharmaceutical Industries Share News
0.000.00%
Last trade - 00:00HealthcareBalancedMid Cap
- $1.62bn
- $735.77m
- $629.18m
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 31 cents a share - Earnings Preview
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
Brief: ISS, Glass Lewis Recommend Taro Shareholders Vote For Merger With Sun Pharma
Australia's Vitura Health set for record drop on potential ops hit on deal fallout
Brief: Taro Announces Extraordinary General Meeting And Ordinary Class Meeting Of Shareholders For Approval Of Merger With Sun Pharmaceutical Industries
Brief: Krensavage Asset Management Says Co Remains Opposed to Sun's Predatory Bid for Taro
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in December - Earnings Summary
Brief: Taro Provides Results For December 31, 2023
Brief: Taro Q3 sales USD 157.145 million
Taro Pharmaceutical Industries Ltd expected to post earnings of 30 cents a share - Earnings Preview
Taro Pharmaceutical Industries Ltd expected to post earnings of 30 cents a share - Earnings Preview
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
India's Sun Pharma hits record high on buying remaining stake in Israeli unit
India's Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mln
Brief: Taro Pharmaceutical Industries Says Under Deal Co, Sun Pharma Have Some Termination Rights Under Some Circumstances Without Payment Of Termination Fee
Brief: Taro Announces Merger Agreement With Sun Pharma
Brief: Sun Pharmaceutical Says Post Delivery Of May 26 Letter, Sun Entered In Price Negotiations With Taro Pharmaceutical